Dr. Thibaud Damy
President of the French Heart Failure and Cardiomyopathy group, French Society of Cardiology
Head of the National Referral Centre for Cardiac Amyloidosis, Co-coordinator of the Mondor Amyloidosis Network, Department of Cardiology, Heart Failure and Amyloidosis Unit and GRC Amyloid Research Institute, all at AP-HP, CHU Henri Mondor, Créteil, France
Professor Thibaud Damy qualified in medicine at the University of Paris XI in 1996. After a period of postgraduate cardiology training in several Parisian hospitals he specialized in heart failure and cardiomyopathy. Professor Damy obtained a PhD on the effect of nitric oxide on heart failure at the University Paris VII in 2004. He was appointed first as a senior registrar at Paris V University (2004), then at Paris XII (2005-2006) and subsequently took up a position in 2007 as a Senior Lecturer in Cardiology and Honorary Consultant Cardiologist at Henri Mondor Hospital, Creteil, France. In August 2008 he obtained a secondment for 16 months as a Senior Research Fellow at the Academic Cardiology Department of Professor John G Cleland at the University of Hull (UK). He was appointed Professor in cardiology in 2011 and became the Head of the Heart failure and Cardiomyopathy unit.
In 2009, with Professor Plante-Bordeneuve he created the “Mondor Amyloidosis Network”, which involves all the clinical facilities for the diagnosis and treatment of amyloidosis in addition to a clinical research team.
Rapidly, Mondor Amyloidosis Network became an important multidisciplinary network involving more than 40 health care professional in the hospital. In 2014, they created the GRC Amyloid Research Institute. Since 2010, more than 1700 patients were referred to the centre for suspicion of Cardiac Amyloidosis. They created a wide educational program to improve the knowledge and quality of life of the patients: Amylo Patient Education Program (Amylo-PEP).
In 2017 the Mondor Amyloidosis Network was appointed by the French health Ministry: National Referral Centre for Cardiac Amyloidosis
Professor Damy’s main field of interest are heart failure, cardiomyopathy and amyloidosis, extending from its epidemiology and physiopathology through to its diagnosis and treatment. Particular current interests include early cardiac diagnosis markers from biology to imaging.